ESR1 and breast cancer: Aberrant activation of FAO is needed for tumour cells to maintain stemness, fuel tumour growth, initiate metastasis, develop drug resistance and evade the immune response [9–13], but the roles of FAO in the tamoxifen resistance of ER-positive BC cells are poorly understood.